Regulation of immune responses by modulation of the function of antigen presenting cells
CA2776874A1
Chaperonin 10 variants
US2011243921A1
Prevention and treatment of cutaneous lupus erythematosus
BRPI0911676A2
cpn10 isolated polypeptide, isolated nucleic acid, expression construct, host cell, antibody, pharmaceutical composition, method for treating or preventing a disease, method for modulating prr signaling, method for modulating the production and / or secretion of one or more immunomodulators, method for inhibiting production and / or secretion of one or more immunomodulators, method of identifying a compound that binds to a polypeptide, method for screening a coprote and a prr ligand and functional variant, derivative, homologue, analog or polypeptide fragment
WO2009124333A1
Modified chaperonin 10 and prr signaling
CA2644058A1
Regulation of immune responses by modulation of the function of antigen presenting cells
CN101330922A
Treatment of hypersensitivity
AU2006303826A1
Treatment of hypersensitivity
AU2006287120A1
Modified chaperonin 10
BRPI0615284A2
modified chaperonin 10
CN101247820A
Chaperonin 10-induced immunomodulation
MX2008000596A
Chaperonin 10-induced immunomodulation.
AU2006269824A1
Chaperonin 10-induced immunomodulation
AU2005204979A1
Chaperonin 10 modulation of toll-like receptor-inducible cytokine and chemokine secretion
CN1921877A
Charperonin 10 modulation of toll-like receptor-inducible cytokine and chemokine secretion
BRPI0506916A
chaperonin 10 modulation of cytokine and chemokine secretion that can be induced by the toll-like receptor
